0 results available. Select is focused ,type to refine list, press Down to open the menu,
Inozyme Pharma, Inc., a clinical-stage rare disease biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases. The compan...
The following section summarizes insights on Inozyme Pharma Inc's Ben Graham Formula Upside:
We've identified the following companies as similar to Inozyme Pharma Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Ben Graham Formula Upside in the valuation category include:
The percentage increase (if positive) or decrease (if negative) an investor can expect over the current stock price based on the Ben Graham Formula Va...
Ben Graham Formula Upside is the percentage upside (if positive) or downside (if negative) implied by the current stock price when compared to Fair Value derived using the Ben Graham Formula.
The chart above depicts the distribution of ben graham formula upside for companies operating in the Healthcare sector in the Developed economic region. Over 2,450 companies were considered in this analysis, and 2,408 had meaningful values. The average ben graham formula upside of companies in the sector is -85.5% with a standard deviation of 32.4%.
Inozyme Pharma Inc's Ben Graham Formula Upside of -100.0% ranks in the 0.0% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,457 |
| Included Constituents | 2,408 |
| Min | -100.0% |
| Max | 93.9% |
| Median | -100.0% |
| Mean | -85.5% |
| Standard Deviation | 32.4% |
You can find companies with similar ben graham formula upside using this stock screener.